Gartner Positions Cigniti Technologies as a “Challenger” in Magic Quadrant for Application Testing Services, Worldwide
Cigniti Technologies, a leading provider of independent software testing services globally, today announced that it has been positioned as a “Challenger” in the Gartner’s 2015 Magic Quadrant for Application Testing Services, Worldwide.1
“We are excited to be positioned as a Challenger in the Gartner’s Magic Quadrant for Application Testing Services and to be assessed for our specialized & IP led software testing services, test automation tools, and flexible delivery models. We believe this achievement further elevates us as a preferred software testing partner for global enterprises and independent software vendors,” says Pradeep Govindasamy – CTO & President, Cigniti Technologies in North America. “We continue to innovate and invest in our end-to-end quality engineering services, which are enabling digital transformation in global enterprises leveraging our SMART Tools™, labs and agile processes, that help our customers accelerate time to market, deliver unparalleled customer experience through superior software and retain their competitive advantage.”
The Magic Quadrant Report assesses 17 of the leading application service providers based on specified inclusion criteria. It reviews each provider's strengths and cautions in the application testing service categories, as well as emphasizes the areas the providers are strong in and the areas that need improvement.
“This recognition as a Challenger in the Gartner’s Magic Quadrant is a game changer for Cigniti and helps us move closer to achieving our goal of becoming the world’s largest and most respected independent software testing services company, which reflects our ability to deliver sustained growth. It is a testimony of strong relationships we have with our clients and trust they have in our specialized testing services,” says Srikanth Chakkilam – Executive Director, Cigniti Technologies. “It strengthens our position to serve global companies across the rest of the world markets that we currently serve, which include UK, EMEA, ANZ and Asia.”
Gartner defines Application Testing Services as “a comprehensive term used to capture all types of verification and validation services for the purposes of supporting quality control and quality assurance (QA) of clients' applications. Verification assesses the technical behavior, and validation assesses the functional behavior of tested elements.”
“The application testing service market, with a copious number of providers, is fast-growing. Both full IT services providers and dedicated, pure-play application testing service providers coexist. By 2018, agile and iterative development will require 30% of resources for application testing engagements to be on-site or onshore,” Gartner says.
Please visit http://www.cigniti.com/analyst-commentary-by-Gartner to view the full report.
About the Magic Quadrant
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
Cigniti Technologies Limited (BSE: 534758, www.cigniti.com), Global Leaders in Independent Software Testing (IST) Services, is headquartered at Hyderabad, India. Cigniti’s 1800+ experts are spread across US, UK, India, Australia, and Canada. Cigniti is the world’s first IST Services Company to be appraised at CMMI-SVC v1.3, Maturity Level 5, and is also ISO 9001:2008 & ISO 27001:2013 certified. Cigniti’s test offerings include services in Quality Engineering, Advisory & Transformation, Next Generation Testing, and Core Testing. With over a decade of experience in serving several 500 fortune enterprises, Cigniti has translated its learning and solutions into SMART Tools™ to accelerate test efforts. Cigniti has India's first of its kind Robotics Test Lab, a Mobile Cloud Test Lab with HP & Experitest, a Cloud enabled Performance Test Lab, and an IoT & Smart Meter Lab. Leading Analysts like Gartner, Forrester, NelsonHall, Everest, Frost & Sullivan, and Forbes recognize Cigniti as a leader in the IST Services space. Cigniti has been awarded a place on the Crown Commercial Service (CCS) G-Cloud 6 framework for providing Lot 4: Specialist Cloud Services that provide PSEs better access to Cigniti's expertise. Cigniti’s CSR initiative, Project Cignificance, aims to impact 1 million+ lives through education as an enabler. For more information write to firstname.lastname@example.org.
1 Gartner “Magic Quadrant for Application Testing Services, Worldwide” by Susanne Matson, Patrick J. Sullivan, 23 November 2015
For Cigniti Technologies
Om Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Følg saker fra Business Wire
Registrer deg med din epostadresse under for å få de nyeste sakene fra Business Wire på epost fortløpende. Du kan melde deg av når som helst.
Siste saker fra Business Wire
Pierre Fabre & Array BioPharma Announce a 62% Observed OS at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO GI Congress23.6.2018 11:00 | Pressemelding
Not intended for UK- and US-based media Pierre Fabre and its partner Array BioPharma Inc. today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAF V600E -mutant metastatic colorectal cancer (CRC). The results showed that, at the time of analysis, the OS data were fully mature through 12.6 months and that the median OS had not yet been reached. The one-year overall survival rate for this cohort was 62%. These data were presented in an oral presentation on Saturday, June 23, at the ESMO 20th World Congress on Gastrointestinal Cancer in Barcelona, Spain. The median progression-free survival (mPFS) for patients treated with the triplet was 8 months [95% CI 5.6-9.3] and is similar between patients receiving one prior line of therapy and patients receiving two prior lines
Compelling Data for LONSURF® (trifluridine/tipiracil) in Metastatic Colorectal Cancer Presented at ESMO’s World Congress on Gastrointestinal Cancer by Servier and Taiho23.6.2018 08:10 | Pressemelding
Servier and Taiho Pharmaceutical Co., Ltd. today announced that the TASCO-1 trial demonstrated promising results for LONSURF® (trifluridine/tipiracil) in combination with bevacizumab in patients with previously untreated metastatic colorectal cancer (mCRC) who are not suitable for intensive treatment, with a median progression-free survival (PFS) of 9.2 months (ranging from 7.6 to 11.5 months). A second non-comparative arm in the trial, evaluated the outcome of patients treated with the current standard of care of capecitabine in combination with bevacizumab. The median PFS of this arm was 7.8 months (ranging from 5.5 to 10.1 months). “Colorectal cancer is the third most common cancer in the world. While there has been some progress in treatment, there are still few options for patients with metastatic disease who are not suitable for intensive treatment,” said Professor Eric Van Cutsem, Head of Digestive Oncology at the University of Leuven, Belgium. “These compelling results suggest
Softomotive and Accelerate RPA Partner to Help Enterprises Achieve Faster Time to Value from RPA22.6.2018 15:13 | Pressemelding
Softomotive, a world–class Robotic Process Automation (RPA) technology provider offering best time to value and affordability for all sizes and types of enterprises, is pleased to announce a strategic partnership with AccelerateRPA, a high calibre professional services provider of trained and certified RPA Consultants within Robotic Process Automation. This partnership means that customers and end users of Softomotive’s software, will have additional knowledgeable and professional guidance available to help achieve significant value quickly from their investment in RPA. Companies who are looking to implement Softomotive’s RPA product suite (WinAutomation and ProcessRobot software) will now have direct access to AccelerateRPA’s highly skilled consultants and Developers. Further, AccelerateRPA has also become a licensed reseller of Softomotive’s products, offering customers a single point of contact for delivering both RPA software and services. Ashley Hudson, Director of AccelerateRPA,
Ascend Performance Materials Announces Price Increase for Intermediate Materials22.6.2018 14:00 | Pressemelding
Ascend Performance Materials announced today a price increase for its intermediate materials. The price increase will take effect globally on July 1, 2018, and includes the following terms: Material Price Increase Terms Hexamethylene diamine (HMD) $0.17/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Acrylonitrile (AN) $0.20/lb. • As contracts allow. • Non-contract business – price determined on an order-by-order basis. Customers should contact their local sales representative for additional information. About Ascend Performance Materials Ascend Performance Materials is a global premium provider of high-quality plastics, fibers and chemicals and is the world’s largest integrated producer of PA66 resin. Headquartered in Houston, Texas, Ascend has eight global locations, including five fully-integrated manufacturing facilities located in the southeastern United States, all dedicated to the innovation and safe production of nylon 6,6. With
Different Countries, Different Customs: Get Ready for the Motorbike Holidays with Moto-tyres.co.uk22.6.2018 13:41 | Pressemelding
Pack your bags, close the boot and get away on holiday? When you start your holidays on a motorcycle, you usually have to consider a few things more when getting ready for your trip. The right preparation is therefore a must. So that nothing stands in the way of a smooth journey, Moto-tyres.co.uk has put together some tips for your next trip. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180622005345/en/ Different countries, different customs: get ready for the motorbike holidays with Moto-tyres.co.uk (Photo: Business Wire) Whether a weekend trip or extended adventure, it all depends on the right equipment. Functional clothing, protectors and rain protection are a must on long trips. Wearing a suitable motorcycle helmet is a legal requirement almost everywhere. However, there are also very different rules and regulations for motorbike equipment and accessories depending on the destination, and you should familiarise yoursel
Boehringer Ingelheim bolsters biologics research and development with 230 million euro investment in new development center22.6.2018 12:00 | Pressemelding
Today Boehringer Ingelheim announced a 230 million euro investment into a new Biologicals Development Center (BDC) at the company’s Research and Development site in Biberach, Germany during the foundation stone laying for the new center. “The BDC is another key building block supporting the company’s long-term strategy for increasing the pipeline’s share of biologicals. This is particularly driven by two of our core areas, immune oncology and immunology,” says Dr. Fridtjof Traulsen, Corporate Senior Vice President Development at Boehringer Ingelheim. “The share of new biological entities in Boehringer Ingelheim’s research pipeline has been consistently increasing over the past few years and has now reached forty percent.” The BDC will help to maximize synergies by integrating biologicals analytical and process development as well as manufacturing for clinical studies into one seamless unit, while at the same time increasing development capacity. Following a staggered launch beginning i